MCID: LCT002
MIFTS: 47

Lactose Intolerance

Categories: Gastrointestinal diseases, Genetic diseases, Metabolic diseases

Aliases & Classifications for Lactose Intolerance

MalaCards integrated aliases for Lactose Intolerance:

Name: Lactose Intolerance 12 26 56 6 44 45 15 64 41 17 74
Lm - Lactose Malabsorption 12
Dairy Product Intolerance 26
Milk Sugar Intolerance 26
Lactose Malabsorption 26
Hypolactasia 26
Alactasia 26

Classifications:



External Ids:

Disease Ontology 12 DOID:10604
MeSH 45 D007787
NCIt 51 C3154
ICD10 34 E73 E73.9
UMLS 74 C0022951

Summaries for Lactose Intolerance

PubMed Health : 64 About lactose intolerance: Stomach ache, bloating, "gas" and diarrhea are all typical digestive symptoms that some people have after eating or drinking dairy products. People who have difficulty digesting dairy products may only tolerate small amounts of lactose (a sugar found in milk and other dairy products). This is called lactose intolerance.But some people who are sensitive to milk might actually have a different problem. It is important to get the diagnosis right before deciding to make major changes to your diet, especially in children, teenagers and people who need more calcium.Lactose intolerance is not an allergy. This is an important difference. People who have a true milk allergy can react to even a tiny amount of dairy foods or milk. But people who are lactose intolerant can sometimes consume quite a lot of these products without having any major problems.

MalaCards based summary : Lactose Intolerance, also known as lm - lactose malabsorption, is related to lactose intolerance, adult type and diarrhea, and has symptoms including nausea and vomiting, constipation and abdominal pain. An important gene associated with Lactose Intolerance is LCT (Lactase), and among its related pathways/superpathways are Glycosaminoglycan metabolism and Galactose metabolism. The drugs Caseins and Chelating Agents have been mentioned in the context of this disorder. Affiliated tissues include testes, small intestine and kidney.

Genetics Home Reference : 26 Lactose intolerance is an impaired ability to digest lactose, a sugar found in milk and other dairy products. Lactose is normally broken down by an enzyme called lactase, which is produced by cells in the lining of the small intestine.

MedlinePlus : 44 Lactose intolerance means that you cannot digest foods with lactose in them. Lactose is the sugar found in milk and foods made with milk. After eating foods with lactose in them, you may feel sick to your stomach. You may also have Gas Diarrhea Swelling in your stomach Your doctor may do a blood, breath or stool test to find out if your problems are due to lactose intolerance. Lactose intolerance is not serious. Eating less food with lactose, or using pills or drops to help you digest lactose usually helps. You may need to take a calcium supplement if you don't get enough of it from your diet, since milk and foods made with milk are the most common source of calcium for most people. NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Wikipedia : 77 Lactose intolerance is a condition in which people have symptoms due to the decreased ability to digest... more...

Related Diseases for Lactose Intolerance

Diseases in the Lactose Intolerance family:

Lactose Intolerance, Adult Type

Diseases related to Lactose Intolerance via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 67)
# Related Disease Score Top Affiliating Genes
1 lactose intolerance, adult type 33.7 LCT MCM6
2 diarrhea 32.1 LCT SI
3 congenital sucrase-isomaltase deficiency with starch and lactose intolerance 12.5
4 lactase deficiency, congenital 11.6
5 congenital short bowel syndrome 11.2
6 osmotic diarrhea 11.2
7 short bowel syndrome 11.2
8 streptococcal group a invasive disease 11.2
9 irritable bowel syndrome 10.6
10 osteoporosis 10.3
11 celiac disease 1 10.2
12 milk allergy 10.2
13 hepatic coma 10.2
14 hepatic encephalopathy 10.2
15 depression 10.2
16 encephalopathy 10.2
17 colorectal cancer 10.1
18 acrodermatitis enteropathica, zinc-deficiency type 10.1
19 cataract 10.1
20 ulcerative colitis 10.1
21 inflammatory bowel disease 10.1
22 colitis 10.1
23 protein-energy malnutrition 10.1
24 gastroenteritis 10.1
25 acrodermatitis 10.1
26 dermatitis 10.1
27 enteropathica 10.1
28 systemic lupus erythematosus 10.1
29 pituitary hormone deficiency, combined, 2 10.1
30 lupus erythematosus 10.1
31 scleroderma, familial progressive 10.0
32 familial mediterranean fever 10.0
33 graves' disease 10.0
34 dumping syndrome 10.0
35 mental depression 10.0
36 diabetes mellitus, noninsulin-dependent 10.0
37 nonalcoholic steatohepatitis 10.0
38 neurofibromatosis, type ii 10.0
39 arteries, anomalies of 10.0
40 hashimoto thyroiditis 10.0
41 ichthyosis bullosa of siemens 10.0
42 ovarian cancer 10.0
43 prostate cancer 10.0
44 urticaria, aquagenic 10.0
45 enterocolitis 10.0
46 retinitis pigmentosa 10.0
47 prostate cancer, hereditary, 8 10.0
48 anxiety 10.0
49 prostate cancer, hereditary, 6 10.0
50 beta-thalassemia 10.0

Graphical network of the top 20 diseases related to Lactose Intolerance:



Diseases related to Lactose Intolerance

Symptoms & Phenotypes for Lactose Intolerance

UMLS symptoms related to Lactose Intolerance:


nausea and vomiting, constipation, abdominal pain, diarrhea, icterus, dyspepsia, heartburn, gastrointestinal gas

Drugs & Therapeutics for Lactose Intolerance

Drugs for Lactose Intolerance (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 27)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Caseins Phase 4,Phase 2,Not Applicable
2 Chelating Agents Phase 4,Not Applicable
3 Bifidobacterium Phase 4,Not Applicable
4 Linoleate Phase 1, Phase 2
5
Sorbitol Approved Not Applicable 50-70-4 5780
6
Chromium Approved 7440-47-3 27668
7
Vitamin A Approved, Nutraceutical, Vet_approved Not Applicable 68-26-8, 22737-96-8, 11103-57-4 9904001 445354
8
Calcium Approved, Nutraceutical ,Not Applicable 7440-70-2 271
9 Retinol palmitate Not Applicable
10 retinol Not Applicable
11 Calcium, Dietary ,Not Applicable
12 Cola ,Not Applicable
13 Antiparasitic Agents Not Applicable
14 Antiprotozoal Agents Not Applicable
15 Anti-Infective Agents Not Applicable
16 Anti-Infective Agents, Urinary Not Applicable
17 Renal Agents Not Applicable
18 Sulfalene Not Applicable
19 Antimalarials Not Applicable
20 Soy Bean Not Applicable
21 insulin Not Applicable
22 Insulin, Globin Zinc Not Applicable
23 Hormones ,Not Applicable
24
Bilirubin Not Applicable 635-65-4, 69853-43-6 21252250 5280352
25 alanine Not Applicable
26 Bone Density Conservation Agents Not Applicable
27 Pharmaceutical Solutions Not Applicable

Interventional clinical trials:

(show all 47)
# Name Status NCT ID Phase Drugs
1 Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance Completed NCT02636413 Phase 4 gaxilose
2 Incidence of Lactose Intolerance Among Self-reported Lactose Intolerant People Completed NCT02878876 Phase 4
3 Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior Completed NCT02406469 Phase 4
4 NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants Completed NCT03219931 Phase 4 Bifidobacterium breve BR03 and Bifidobacterium breve B632;Placebos
5 Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome Withdrawn NCT02190526 Phase 4 Mesalazine(asacol 800 mg);Amitriptyline;placebo like asacol;placebo like amitriptyline
6 Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance Completed NCT02673749 Phase 2, Phase 3 RP-G28
7 A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia Completed NCT01145586 Phase 3 Lactase Oral Tablets
8 A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI) Completed NCT01145339 Phase 3 Lactase
9 Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance Active, not recruiting NCT03597516 Phase 3 RP-G28;Placebos
10 Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy Unknown status NCT02149134 Phase 2
11 Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance Completed NCT01113619 Phase 2 RP-G28 or placebo;RP-G28 or placebo
12 Cheese Intake,CLA and Hypercholesterolemia Completed NCT01561846 Phase 1, Phase 2
13 Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects Completed NCT03563846 Phase 1 RP-G28
14 The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese Population Unknown status NCT01286597 Not Applicable
15 Whole Milk Intake and Cardio-metabolic Risk Factors Unknown status NCT02798718 Not Applicable
16 Perceived Lactose Intolerance Completed NCT01331265
17 Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls Completed NCT02171403
18 Secondary Lactose Intolerance Due to Chronic Norovirus Infection Completed NCT01840891 Not Applicable
19 The Effect of Probiotics on Lactose Intolerance Completed NCT01593800 Not Applicable
20 β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion Completed NCT02518295 Not Applicable
21 Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis Completed NCT00403923
22 Effects of Raw Versus Other Milk Sources on Lactose Digestion Completed NCT01129791 Not Applicable
23 Amount of Lactose Causing Symptoms in Lactose Intolerant People Completed NCT00395954
24 Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies Completed NCT02902016 Not Applicable GED
25 Althera® Versus Nutramigen / Cow's Milk Intolerance Completed NCT01727115 Not Applicable
26 Acid Lactase in Combination With Yoghurt Bacteria for Improvement of Lactose Digestion in Lactose Malabsorbers Completed NCT01593631 Not Applicable
27 HYBRID: Hydrogen Breath Test in Lactose Digestion Completed NCT02703987 Not Applicable
28 Effects of Lactose on Fecal Microflora Completed NCT00599859 Not Applicable
29 Calcium Absorption in Postmenopausal Thai Women Completed NCT02291315
30 Colonization and Persistence of Bifidobacterium Longum Completed NCT01650753 Not Applicable
31 Endomicroscopy, IBS and Food Intolerance Completed NCT01692613
32 Effect of Fructose on Colonic Microflora Completed NCT00775567 Not Applicable
33 Post-exercise Recovery After Dietary Protein Ingestion in Healthy Young Men (Meat-Milk Study) Completed NCT01578590 Not Applicable
34 Observational Study With PASCALLERG ® in Patients With Hay Fever Completed NCT01660737
35 "Functional Bowel Disorder. Investigation in General Practice" Completed NCT01153295 Not Applicable
36 Improving Bone Health in Adolescence Through Targeted Behavioral Intervention Completed NCT02202889 Not Applicable
37 Lactose Intolerance and Cow's Milk Protein Allergy in Non-celiac Wheat Sensitivity Patients Recruiting NCT03008252
38 Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders Recruiting NCT02085889
39 Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults. Recruiting NCT03860051
40 Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution Recruiting NCT03814668 Not Applicable
41 Comparing the Digestion of Milk With Different Beta-casein Protein Content by Dairy Intolerant Persons Recruiting NCT03713346 Not Applicable
42 Effects of A2 Milk on Gastrointestinal Function in Non-lactose Milk Intolerance Active, not recruiting NCT03060395 Not Applicable
43 Effect of B.Bifidum 900791 Intake in Adult With Hypolactasia and Lactose Intolerance Not yet recruiting NCT03952988 Not Applicable
44 Clinical Utility of Breath Tests in GI Not yet recruiting NCT03261856
45 Prevalence of Lactose Intolerance Following Stem Cell Transplantation Terminated NCT00247806
46 Evaluation of Fecal Calprotectin Screening and a Gastroenterology Questionnaire for Triaging Children With Chronic Abdominal Pain and/or Diarrhea Referred to a Pediatric Gastroenterology Service Terminated NCT01866774 Not Applicable
47 Validation of a Home-screening Test for Lactose Intolerance Withdrawn NCT00844766

Search NIH Clinical Center for Lactose Intolerance

Cochrane evidence based reviews: lactose intolerance

Genetic Tests for Lactose Intolerance

Anatomical Context for Lactose Intolerance

MalaCards organs/tissues related to Lactose Intolerance:

42
Testes, Small Intestine, Kidney, Colon, Bone, Prostate, Thyroid

Publications for Lactose Intolerance

Articles related to Lactose Intolerance:

(show top 50) (show all 463)
# Title Authors Year
1
Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study. ( 31010241 )
2019
2
Lactose Intolerance and Bone Health: The Challenge of Ensuring Adequate Calcium Intake. ( 30925689 )
2019
3
Lactose intolerance: what is a correct management? ( 30892454 )
2019
4
The First Report about the Laparoscopic Sleeve Gastrectomy-Induced Lactose Intolerance. ( 30627988 )
2019
5
Use of a Novel Probiotic Formulation to Alleviate Lactose Intolerance Symptoms-a Pilot Study. ( 30617948 )
2019
6
Genetic predictors of celiac disease, lactose intolerance, and vitamin D function and presence of peptide morphins in urine of children with neurodevelopmental disorders. ( 28738753 )
2019
7
Lactose intolerance but not lactose maldigestion is more frequent in patients with irritable bowel syndrome than in healthy controls: A meta-analysis. ( 30560578 )
2018
8
Lactose Intolerance: Common Misunderstandings. ( 30783042 )
2018
9
Lactase deficiency and lactose intolerance in a multiracial Asian population in Malaysia. ( 30619942 )
2018
10
Lactose Intolerance, Dairy Avoidance, and Treatment Options. ( 30558337 )
2018
11
Gender, Age, Race and Lactose Intolerance: Is There Evidence to Support a Differential Symptom Response? A Scoping Review. ( 30544891 )
2018
12
Analysis of lactase in lactose intolerance supplements. ( 30462373 )
2018
13
Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus. ( 30332787 )
2018
14
Caries in children with lactose intolerance and cow's milk protein allergy. ( 30231171 )
2018
15
An Electronic Questionnaire Survey Evaluating the Perceived Prevalence and Practices of Lactose Intolerance in 1 to 5 Year Old Children in South East Asia. ( 29992116 )
2018
16
Managing acute pain in patients who report lactose intolerance: the safety of an old excipient re-examined. ( 29796247 )
2018
17
One-third of children with lactose intolerance managed to achieve a regular diet at the three-year follow-up point. ( 29505134 )
2018
18
The effects of probiotics in lactose intolerance: A systematic review. ( 29425071 )
2018
19
Prevalence, cause and diagnosis of lactose intolerance in children aged 1-5 years: a systematic review of 1995-2015 literature. ( 29222879 )
2018
20
Lactose intolerance and gastrointestinal cow's milk allergy in infants and children - common misconceptions revisited. ( 29270244 )
2017
21
Lactose Intolerance and Colorectal Cancer. ( 29159160 )
2017
22
Successful Treatment With Phenobarbital Following Lactase Supplementation in an Infant With Lactose Intolerance. ( 28821216 )
2017
23
Lactose Intolerance (LCT-13910C>T) Genotype Is Associated with Plasma 25-Hydroxyvitamin D Concentrations in Caucasians: A Mendelian Randomization Study. ( 28446633 )
2017
24
Lactase Non-persistence and Lactose Intolerance. ( 28421381 )
2017
25
Comparison of an increased waist circumference with a positive hydrogen breath test as a clinical predictor of lactose intolerance. ( 28318180 )
2017
26
Diagnosis of genetic predisposition for lactose intolerance by high resolution melting analysis. ( 28132945 )
2017
27
Diagnosis of lactose intolerance. ( 28038856 )
2017
28
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine. ( 27577569 )
2017
29
Recent advances on lactose intolerance: Tolerance thresholds and currently available answers. ( 26713460 )
2017
30
Prevalence of lactose intolerance in patients with diarrhea-predominant irritable bowel syndrome: data from a tertiary center in southern China. ( 29157302 )
2017
31
Lactose Intolerance and Symptom Pattern of Lactose Intolerance among Healthy Volunteers. ( 29201715 )
2016
32
Erratum to: the effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial. ( 27716234 )
2016
33
ORAL ADMINISTRATION OF EXOGENOUS LACTASE IN TABLETS FOR PATIENTS DIAGNOSED WITH LACTOSE INTOLERANCE DUE TO PRIMARY HYPOLACTASIA. ( 27706451 )
2016
34
A relationship between vitamin D, parathyroid hormone, calcium levels and lactose intolerance in type 2 diabetic patients and healthy subjects. ( 27642086 )
2016
35
Differentiating milk allergy (IgE and non-IgE mediated) from lactose intolerance: understanding the underlying mechanisms and presentations. ( 27481986 )
2016
36
The effects of the DDS-1 strain of lactobacillus on symptomatic relief for lactose intolerance - a randomized, double-blind, placebo-controlled, crossover clinical trial. ( 27207411 )
2016
37
Perception of lactose intolerance impairs health-related quality of life. ( 27188918 )
2016
38
Do patients with lactose intolerance exhibit more frequent comorbidities than patients without lactose intolerance? An analysis of routine data from German medical practices. ( 27065730 )
2016
39
The incidence of infants with rotavirus enteritis combined with lactose intolerance. ( 27005498 )
2016
40
Clinical evaluation, biochemistry and genetic polymorphism analysis for the diagnosis of lactose intolerance in a population from northeastern Brazil. ( 26934237 )
2016
41
Prevalence and Symptom Correlation of Lactose Intolerance in the North East Part of Bangladesh. ( 26931253 )
2016
42
Lactase persistence versus lactose intolerance: Is there an intermediate phenotype? ( 26601570 )
2016
43
Prevalence of Lactose Malabsorption and Lactose Intolerance in Pediatric Patients with Selected Gastrointestinal Diseases. ( 26768639 )
2015
44
Lactose intolerance. ( 26715083 )
2015
45
Lactose intolerance in Indonesian children. ( 26715082 )
2015
46
The Interrelationships between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds. ( 26404364 )
2015
47
Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. ( 26393648 )
2015
48
Contribution of Colonic Fermentation and Fecal Water Toxicity to the Pathophysiology of Lactose-Intolerance. ( 26371036 )
2015
49
The Diverse Forms of Lactose Intolerance and the Putative Linkage to Several Cancers. ( 26343715 )
2015
50
The management of lactose intolerance among primary care physicians and its correlation with management by gastroenterologists: the SEPD-SEMG national survey. ( 26334462 )
2015

Variations for Lactose Intolerance

ClinVar genetic disease variations for Lactose Intolerance:

6 (show top 50) (show all 122)
# Gene Variation Type Significance SNP ID Assembly Location
1 LCT NM_002299.3(LCT): c.*251G> A single nucleotide variant Uncertain significance rs886054860 GRCh38 Chromosome 2, 135788073: 135788073
2 LCT NM_002299.3(LCT): c.*251G> A single nucleotide variant Uncertain significance rs886054860 GRCh37 Chromosome 2, 136545643: 136545643
3 LCT NM_002299.3(LCT): c.*10A> C single nucleotide variant Uncertain significance rs200994158 GRCh38 Chromosome 2, 135788314: 135788314
4 LCT NM_002299.3(LCT): c.*10A> C single nucleotide variant Uncertain significance rs200994158 GRCh37 Chromosome 2, 136545884: 136545884
5 LCT NM_002299.3(LCT): c.5771T> C (p.Val1924Ala) single nucleotide variant Uncertain significance rs886054861 GRCh38 Chromosome 2, 135788337: 135788337
6 LCT NM_002299.3(LCT): c.5771T> C (p.Val1924Ala) single nucleotide variant Uncertain significance rs886054861 GRCh37 Chromosome 2, 136545907: 136545907
7 LCT NM_002299.3(LCT): c.5656G> A (p.Val1886Ile) single nucleotide variant Uncertain significance rs376732886 GRCh38 Chromosome 2, 135788452: 135788452
8 LCT NM_002299.3(LCT): c.54G> C (p.Trp18Cys) single nucleotide variant Uncertain significance rs886054870 GRCh37 Chromosome 2, 136594686: 136594686
9 LCT NM_002299.3(LCT): c.54G> C (p.Trp18Cys) single nucleotide variant Uncertain significance rs886054870 GRCh38 Chromosome 2, 135837116: 135837116
10 LCT NM_002299.3(LCT): c.729C> G (p.Val243=) single nucleotide variant Likely benign rs3816088 GRCh37 Chromosome 2, 136587238: 136587238
11 LCT NM_002299.3(LCT): c.729C> G (p.Val243=) single nucleotide variant Likely benign rs3816088 GRCh38 Chromosome 2, 135829668: 135829668
12 LCT NM_002299.3(LCT): c.1396G> T (p.Gly466Trp) single nucleotide variant Uncertain significance rs377102890 GRCh37 Chromosome 2, 136575222: 136575222
13 LCT NM_002299.3(LCT): c.1396G> T (p.Gly466Trp) single nucleotide variant Uncertain significance rs377102890 GRCh38 Chromosome 2, 135817652: 135817652
14 LCT NM_002299.3(LCT): c.2457C> T (p.His819=) single nucleotide variant Uncertain significance rs149425549 GRCh37 Chromosome 2, 136567460: 136567460
15 LCT NM_002299.3(LCT): c.2457C> T (p.His819=) single nucleotide variant Uncertain significance rs149425549 GRCh38 Chromosome 2, 135809890: 135809890
16 LCT NM_002299.3(LCT): c.2760C> T (p.Gly920=) single nucleotide variant Uncertain significance rs200579267 GRCh37 Chromosome 2, 136567157: 136567157
17 LCT NM_002299.3(LCT): c.2760C> T (p.Gly920=) single nucleotide variant Uncertain significance rs200579267 GRCh38 Chromosome 2, 135809587: 135809587
18 LCT NM_002299.3(LCT): c.3390G> A (p.Glu1130=) single nucleotide variant Uncertain significance rs886054865 GRCh37 Chromosome 2, 136566527: 136566527
19 LCT NM_002299.3(LCT): c.3390G> A (p.Glu1130=) single nucleotide variant Uncertain significance rs886054865 GRCh38 Chromosome 2, 135808957: 135808957
20 LCT NM_002299.3(LCT): c.3532C> T (p.Leu1178=) single nucleotide variant Uncertain significance rs886054864 GRCh37 Chromosome 2, 136566385: 136566385
21 LCT NM_002299.3(LCT): c.3532C> T (p.Leu1178=) single nucleotide variant Uncertain significance rs886054864 GRCh38 Chromosome 2, 135808815: 135808815
22 LCT NM_002299.3(LCT): c.3595G> A (p.Ala1199Thr) single nucleotide variant Uncertain significance rs886054863 GRCh37 Chromosome 2, 136566322: 136566322
23 LCT NM_002299.3(LCT): c.3595G> A (p.Ala1199Thr) single nucleotide variant Uncertain significance rs886054863 GRCh38 Chromosome 2, 135808752: 135808752
24 LCT NM_002299.3(LCT): c.3986C> T (p.Thr1329Met) single nucleotide variant Uncertain significance rs555708380 GRCh37 Chromosome 2, 136564885: 136564885
25 LCT NM_002299.3(LCT): c.3986C> T (p.Thr1329Met) single nucleotide variant Uncertain significance rs555708380 GRCh38 Chromosome 2, 135807315: 135807315
26 LCT NM_002299.3(LCT): c.4239A> G (p.Pro1413=) single nucleotide variant Uncertain significance rs752925060 GRCh37 Chromosome 2, 136562562: 136562562
27 LCT NM_002299.3(LCT): c.4239A> G (p.Pro1413=) single nucleotide variant Uncertain significance rs752925060 GRCh38 Chromosome 2, 135804992: 135804992
28 LCT NM_002299.3(LCT): c.5493C> T (p.Tyr1831=) single nucleotide variant Uncertain significance rs369410973 GRCh37 Chromosome 2, 136547211: 136547211
29 LCT NM_002299.3(LCT): c.5493C> T (p.Tyr1831=) single nucleotide variant Uncertain significance rs369410973 GRCh38 Chromosome 2, 135789641: 135789641
30 LCT NM_002299.3(LCT): c.5656G> A (p.Val1886Ile) single nucleotide variant Uncertain significance rs376732886 GRCh37 Chromosome 2, 136546022: 136546022
31 LCT NM_002299.3(LCT): c.318C> T (p.Asp106=) single nucleotide variant Likely benign rs34307240 GRCh37 Chromosome 2, 136594422: 136594422
32 LCT NM_002299.3(LCT): c.318C> T (p.Asp106=) single nucleotide variant Likely benign rs34307240 GRCh38 Chromosome 2, 135836852: 135836852
33 LCT NM_002299.3(LCT): c.319G> A (p.Glu107Lys) single nucleotide variant Uncertain significance rs761296720 GRCh37 Chromosome 2, 136594421: 136594421
34 LCT NM_002299.3(LCT): c.319G> A (p.Glu107Lys) single nucleotide variant Uncertain significance rs761296720 GRCh38 Chromosome 2, 135836851: 135836851
35 LCT NM_002299.3(LCT): c.454G> A (p.Ala152Thr) single nucleotide variant Likely benign rs114525655 GRCh37 Chromosome 2, 136594286: 136594286
36 LCT NM_002299.3(LCT): c.454G> A (p.Ala152Thr) single nucleotide variant Likely benign rs114525655 GRCh38 Chromosome 2, 135836716: 135836716
37 LCT NM_002299.3(LCT): c.1419C> A (p.Gly473=) single nucleotide variant Benign rs6719488 GRCh37 Chromosome 2, 136575199: 136575199
38 LCT NM_002299.3(LCT): c.1419C> A (p.Gly473=) single nucleotide variant Benign rs6719488 GRCh38 Chromosome 2, 135817629: 135817629
39 LCT NM_002299.3(LCT): c.1650C> G (p.Gly550=) single nucleotide variant Likely benign rs35093754 GRCh37 Chromosome 2, 136574968: 136574968
40 LCT NM_002299.3(LCT): c.1650C> G (p.Gly550=) single nucleotide variant Likely benign rs35093754 GRCh38 Chromosome 2, 135817398: 135817398
41 LCT NM_002299.3(LCT): c.1780C> G (p.Gln594Glu) single nucleotide variant Uncertain significance rs886054867 GRCh37 Chromosome 2, 136570454: 136570454
42 LCT NM_002299.3(LCT): c.1780C> G (p.Gln594Glu) single nucleotide variant Uncertain significance rs886054867 GRCh38 Chromosome 2, 135812884: 135812884
43 LCT NM_002299.3(LCT): c.3341A> G (p.Gln1114Arg) single nucleotide variant Uncertain significance rs148838160 GRCh37 Chromosome 2, 136566576: 136566576
44 LCT NM_002299.3(LCT): c.3341A> G (p.Gln1114Arg) single nucleotide variant Uncertain significance rs148838160 GRCh38 Chromosome 2, 135809006: 135809006
45 LCT NM_002299.3(LCT): c.3599C> T (p.Thr1200Met) single nucleotide variant Uncertain significance rs148317168 GRCh37 Chromosome 2, 136566318: 136566318
46 LCT NM_002299.3(LCT): c.3599C> T (p.Thr1200Met) single nucleotide variant Uncertain significance rs148317168 GRCh38 Chromosome 2, 135808748: 135808748
47 LCT NM_002299.3(LCT): c.3759G> A (p.Thr1253=) single nucleotide variant Uncertain significance rs764860323 GRCh37 Chromosome 2, 136566158: 136566158
48 LCT NM_002299.3(LCT): c.3759G> A (p.Thr1253=) single nucleotide variant Uncertain significance rs764860323 GRCh38 Chromosome 2, 135808588: 135808588
49 LCT NM_002299.3(LCT): c.4026G> A (p.Thr1342=) single nucleotide variant Uncertain significance rs150640616 GRCh37 Chromosome 2, 136564845: 136564845
50 LCT NM_002299.3(LCT): c.4026G> A (p.Thr1342=) single nucleotide variant Uncertain significance rs150640616 GRCh38 Chromosome 2, 135807275: 135807275

Expression for Lactose Intolerance

Search GEO for disease gene expression data for Lactose Intolerance.

Pathways for Lactose Intolerance

GO Terms for Lactose Intolerance

Cellular components related to Lactose Intolerance according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.1 ANPEP ATP12A DOCK4 LCT SI TREH

Biological processes related to Lactose Intolerance according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 metabolic process GO:0008152 9.13 LCT SI TREH
2 polysaccharide digestion GO:0044245 8.62 LCT SI

Molecular functions related to Lactose Intolerance according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hydrolase activity, hydrolyzing O-glycosyl compounds GO:0004553 9.16 LCT SI
2 hydrolase activity, acting on glycosyl bonds GO:0016798 9.13 LCT SI TREH
3 hydrolase activity GO:0016787 9.1 ANPEP ATP12A LCT MCM6 SI TREH

Sources for Lactose Intolerance

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....